Evidence map›Paper›PMID 40029927›Full record

ArticlePloS one2025

Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease.

Shaylah McCool, Jennie C Smith, Asia Sladek, Shan Fan, Matthew J Van Hook

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaylah McCoolDepartment of Ophthalmology & Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.ORCID https://orcid.org/0000-0001-7486-6665
Jennie C SmithDepartment of Ophthalmology & Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.ORCID https://orcid.org/0000-0002-3167-0598
Asia SladekDepartment of Ophthalmology & Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Shan FanDepartment of Ophthalmology & Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Matthew J Van HookDepartment of Ophthalmology & Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.ORCID https://orcid.org/0000-0003-1615-4314

Funding

Influence of ocular hypertension on neurons and synapses in the visual thalamusR01EY030507 · NEI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI VAN HOOK, MATTHEW JOHN · 2019 to 2023
$1.9M
UNMC Training Program in Alzheimer’s Disease and Related Dementias Drug DiscoveryT32AG076407 · NIA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOWARD S FOX, Paul Trippier · 2022 to 2026
$1.1M
NEI NIH HHS R01 EY030507NIA NIH HHS T32 AG076407
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the formation of amyloid beta (Aβ) plaques and neurofibrillary tangles that lead to decreased quality of life due to behavioral, motor, and cognitive impairments. Due to the widespread pathological nature of AD, many brain regions are affected by Aβ plaques including regions important for vision such as the lateral geniculate nucleus (LGN) of the thalamus which is critical for relaying signals from the retina to the primary visual cortex. Using a wide range of techniques including electrophysiological approaches, in vivo and ex vivo imaging methods, and immunohistochemistry in a mouse model with progressing amyloidosis (5xFAD), the goal of this study was to determine whether AD-like pathology disrupts neuronal and synaptic structure and function in the visual system. In vivo electroretinogram recordings revealed photoreceptor dysfunction in the 6- and 9-month-old 5xFAD mice, while optical coherence tomography indicated no changes in 5xFAD retinal thickness from 9 to 12 months. In the dorsolateral geniculate nucleus (dLGN), the rodent homolog of the primate LGN, we identified decreased densities of retinal ganglion cell axon terminals and fewer thalamocortical (TC) neuron cell bodies. No detectable deficits in excitatory synaptic function or TC neuron dendritic structure were seen in the dLGN, and reflexive visual behavior was also found to be normal in the 5xFAD mice. These results indicate relatively modest amyloid-triggered dysfunction in these stages of the visual system suggesting that Aβ plaque formation may play only a small role in the visual system dysfunction seen in AD patients. These results may also point to potential compensatory mechanisms that preserve function of visual pathways in the 5xFAD visual system.

Indexed as

Alzheimer DiseaseRetinaThalamusAmyloid beta-PeptidesAnimalsDisease Models, AnimalElectroretinographyGeniculate BodiesMaleMiceMice, TransgenicRetinal Ganglion CellsTomography, Optical CoherenceAmyloid beta-Peptides

Identifiers

PMID40029927
PMCPMC11875347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.